Multiple Sclerosis Clinical Trials

Showing 5521-5540 of 5,960 trials

Cranberry for Prevention of Urinary Tract Infections in Multiple Sclerosis Patients

NCT00280592

Bladder dysfunction occurs at some time in most patients with multiple sclerosis and these patients are prone to have recurrent urinary tract infections. Cranberry has been traditionally used for the treatment and prophylaxis of urinary tract infections but there is no reliable randomized controlled trial demonstrating evidence of cranberry's utility in this disease. The aim of our study is to assess the efficacy and safety of cranberry in the prophylaxis of urinary tract infections in patients with multiple sclerosis with a prospective randomized, double-blind and placebo-controlled clinical trial.

Multiple SclerosisUrinary Tract InfectionsBladder Dysfunction

Rennes University Hospital171 participantsStarted Jan 2006

Besançon, France • Bordeaux, France • Garches, France +7 more locations

COMPLETEDPhase 1

Safety And Pharmacology Of SNX-5422 Mesylate In Subjects With Refractory Hematological Malignancies

NCT00595686

Hsp90 is a chemical in the body that is involved in the promotion of cancer. SNX-5422 is an experimental drug that blocks Hsp90. It is being evaluated for safety and efficacy in patients with cancer.

Hematologic Neoplasms

Esanex Inc.25 participantsStarted Jan 2008

Augusta, Georgia, United States • Chapel Hill, North Carolina, United States • Pittsburgh, Pennsylvania, United States +1 more locations

Cranberry for Prevention of Urinary Tract Infections in Multiple Sclerosis Patients

Safety And Pharmacology Of SNX-5422 Mesylate In Subjects With Refractory Hematological Malignancies

Related Searches

First-in-human Study of AB0024 to Evaluate Safety and Tolerability in Adults With Advanced Solid Tumors

Safety Study of High Dose Temozolomide to Treat Relapsed/Refractory Central Nervous System (CNS) Malignancy

Comprehensibility of Colorectal Cancer Screening Educational Materials: Effects on Patient Knowledge and Motivation

Sorafenib Combined With Transarterial Chemoembolization in Treating HBV-infected Patients With Intermediate Hepatocellular Carcinoma

Efficacy Study of Weekly Taxotere and Topotecan for Recurrent Gynecologic (GYN) Cancers

A Safety and Efficacy Study of CNTO1275 in Patients With Multiple Sclerosis

EPO906 Therapy in Patients With Advanced Kidney Cancer

Efficacy and Safety of Fingolimod in Patients With Relapsing-remitting Multiple Sclerosis

Study Evaluating the Effect of Sirolimus on Non-Melanoma Skin Cancer in Kidney Transplant Recipients

p53 Gene Therapy for Head and Neck Malignant Tumors in Advanced Stage

Youth Empowerment Solutions for Peaceful Communities

Investigational Agent AG-013736 In Combinations With Standard Of Care Treatments For Patient's With Advanced Solid Tumor

Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin for Children With Peritoneal Cancer

Study of Lapatinib in Breast Cancer Patients With HER-2 Non-amplified Primary Tumors and HER-2 Positive or EGFR Positive Circulating Tumor Cells

A Study Of PF-03732010 In Patients With Advanced Solid Tumors

Feasibility Study of Pazopanib in Combination With Chemotherapy in Gynaecological Tumors

Sensori-motor Integration Training in Multiple Sclerosis

Helicobacter Pylori Eradication After Endoscopic Resection of Gastric Tumors